SYMPOSIUM–TRANSLATIONAL DRUG DISCOVERY: THE VALUE OF ANIMAL MODELS AND ORGANOIDS

Wednesday March 29
HALL G3
14:45-15:00
MODELING LATE-ONSET ALZHEIMER’S DISEASE IN MICE

SYMPOSIUM–SELECTIVE VULNERABILITY, GLIAL CELLS AND MECHANISMS OF NEURDEGENERATION

Wednesday March 29
HALL G2
17:20-17:35
SPATIOTEMPORAL TRANSCRIPTOMIC CHARACTERIZATION OF ALZHEIMER’S DISEASE

ON-DEMAND ORAL PRESENTATIONS

OD023 / #650
IN VIVO VALIDATION OF LATE-ONSET ALZHEIMER’S DISEASE GENETIC RISK FACTORS IN MOUSE MODELS

OD026 / #2795
LONGITUDINAL TRANSCRIPTOMIC SIGNATURES ACROSS GENETICALLY DIVERSE MOUSE MODELS OF ALZHEIMER’S DISEASE STRATIFY BY SPECIFIC IMMUNE AND METABOLIC PROCESSES

POSTERS

P0375 / #366
WHOLE-BRAIN IMAGING AND ANALYSIS OF AMYLOID-BETA PLAQUE DYNAMICS IN PRE-CLINICAL ALZHEIMER’S DISEASE ANIMAL MODELS

P0222 / #486
PHARMACODYNAMICS ASSESSMENT OF ADUCANUMAB IN 5XFAD MICE : A MODEL-AD PTC STUDY

P0557 / #857
COMPARATIVE CHARACTERIZATION OF 5XFAD AND HABETASAA MOUSE MODELS OF FAMILIAL AD MUTATIONS

P0489 / #1017
DETERMINING HOW A KLOTHO GENETIC VARIANT SUPPRESSES APOE4 RISK USING NOVEL MOUSE MODELS

P0560 / #1084
COMBINING AGING, GENETIC RISK AND ENVIRONMENTAL FACTORS TO IMPROVE TRANSLATIONAL VALIDITY OF ANIMAL MODELS FOR PRECLINICAL TESTING FOR ALZHEIMER’S DISEASE

P1028 / #1223
IDENTIFYING METABOLIC AND VASCULAR CONTRIBUTIONS TO NEURODEGENERATION USING A NEW PRECLINICAL MODEL FOR ADRDS

P0545 / #1233
AN INTEGRATIVE MULTI-OMICS APPROACH REVEALS MOLECULAR SIGNATURES ASSOCIATED WITH AGE AND HIGH-FAT DIET IN MOUSE MODELS OF ALZHEIMER’S DISEASE

P0559 / #2454
A CLU/APOJ GWAS AD RISK VARIANT SUPPRESSES THE ASTROCYTIC RESPONSE TO PLAQUES AND REDUCES AXONAL AND NEURITIC DAMAGE IN 5XFAD MICE

P0561 / #2344
LATE-ONSET AD RISK MUTATION PICALM*H458R INITIALLY PREVENTS PLAQUE GENERATION IN 5XFAD MICE